Brief: Theranexus FY Net Loss Widens To 2.1 Million Euros

Thx Pharma SA

26/04/2018 18:18

April 26 (Reuters) - THERANEXUS SA  ALTHX.PA :
    * FY OPERATING LOSS EUR 2.7 MILLION VERSUS EUR 2.1 MILLION
YEAR
AGO
    * FY NET LOSS EUR 2.1 MILLION VERSUS LOSS OF EUR 1.6 MILLION
YEAR
AGO
    * END-DEC CASH AND CASH EQUIVALENTS EUR 18.2 MILLION
    * WE ARE ACCELERATING OUR CLINICAL DEVELOPMENTS IN 2018,
WITH
IMPORTANT FIRST MILESTONES - CEO
    * 2018  MILESTONES: OBTAINING APPROVALS FOR PHASE 2 CLINICAL
TRIALS FOR THN102 IN PARKINSON'S DISEASE IN A FIRST EUROPEAN
COUNTRY AND IN UNITED STATES - CEO

Source text for Eikon:  ID:nACT52954 
Further company coverage:  ALTHX.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;))